Lipoprotein Lipase from Macrophages Helps Reduce High Triglycerides in Mice
Author Information
Author(s): Ding Yinyuan, Zhang Ling, Wang Yuhui, Huang Wei, Tang Yin, Bai Lu, Ross Colin J. D., Hayden Michael R., Liu George
Primary Institution: Institute of Cardiovascular Sciences and Key Laboratory of Molecular Cardiovascular Sciences, Peking University, Beijing, China
Hypothesis
Can macrophage-derived lipoprotein lipase (LPL) improve plasma lipid metabolism in LPL-deficient mice?
Conclusion
Hematopoietic cell-derived LPL can significantly reduce severe hypertriglyceridemia and hypo-alpha-cholesterolemia in LPL-deficient mice.
Supporting Evidence
- LPL+/+ → LPL-/- mice showed significant reductions in plasma triglyceride and cholesterol levels.
- Plasma HDL cholesterol levels increased significantly in LPL+/+ → LPL-/- mice compared to controls.
- The introduction of LPL from hematopoietic cells improved fat metabolism in LPL-deficient mice.
Takeaway
Researchers found that a special type of fat-processing enzyme from immune cells can help mice with a fat problem get better, even when their usual fat-processing enzymes are missing.
Methodology
LPL-deficient mice were transplanted with bone marrow from wild-type or LPL-deficient mice, and plasma lipid levels were measured over 16 weeks.
Limitations
The study was conducted in a mouse model, which may not fully replicate human conditions.
Participant Demographics
LPL-deficient C57BL/6 mice
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website